Rommelaere J - Search Results

1

Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model.

Raykov Z, Grekova S, Galabov AS, Balboni G, Koch U, Aprahamian M, Rommelaere J. Raykov Z, et al. Among authors: rommelaere j. Oncol Rep. 2007 Jun;17(6):1493-9. Oncol Rep. 2007. PMID: 17487410

2

Transient suppression of transgene expression by means of antisense oligonucleotides: a method for the production of toxin-transducing recombinant viruses.

Raykov Z, Legrand V, Homann HE, Rommelaere J. Raykov Z, et al. Among authors: rommelaere j. Gene Ther. 2002 Mar;9(5):358-62. doi: 10.1038/sj.gt.3301660. Gene Ther. 2002. PMID: 11938456

3

Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases.

Raykov Z, Balboni G, Aprahamian M, Rommelaere J. Raykov Z, et al. Among authors: rommelaere j. Int J Cancer. 2004 May 1;109(5):742-9. doi: 10.1002/ijc.20013. Int J Cancer. 2004. PMID: 14999784

4

Cancer gene therapy through autonomous parvovirus--mediated gene transfer.

Cornelis JJ, Lang SI, Stroh-Dege AY, Balboni G, Dinsart C, Rommelaere J. Cornelis JJ, et al. Among authors: rommelaere j. Curr Gene Ther. 2004 Sep;4(3):249-61. doi: 10.2174/1566523043346228. Curr Gene Ther. 2004. PMID: 15384939 Review.

5

B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression.

Raykov Z, Savelyeva L, Balboni G, Giese T, Rommelaere J, Giese NA. Raykov Z, et al. Among authors: rommelaere j. J Virol. 2005 Mar;79(6):3517-24. doi: 10.1128/JVI.79.6.3517-3524.2005. J Virol. 2005. PMID: 15731246 Free PMC article.

6

Oncolytic potential of rodent parvoviruses for cancer therapy in humans: a brief review.

Geletneky K, Herrero Y Calle M, Rommelaere J, Schlehofer JR. Geletneky K, et al. Among authors: rommelaere j. J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):327-30. doi: 10.1111/j.1439-0450.2005.00877.x. J Vet Med B Infect Dis Vet Public Health. 2005. PMID: 16316394 Review.

7

Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells.

Abschuetz A, Kehl T, Geibig R, Leuchs B, Rommelaere J, Régnier-Vigouroux A. Abschuetz A, et al. Among authors: rommelaere j. Cell Tissue Res. 2006 Sep;325(3):423-36. doi: 10.1007/s00441-006-0199-z. Epub 2006 May 3. Cell Tissue Res. 2006. PMID: 16699801

8

Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells.

Di Piazza M, Mader C, Geletneky K, Herrero Y Calle M, Weber E, Schlehofer J, Deleu L, Rommelaere J. Di Piazza M, et al. Among authors: rommelaere j. J Virol. 2007 Apr;81(8):4186-98. doi: 10.1128/JVI.02601-06. Epub 2007 Feb 7. J Virol. 2007. PMID: 17287256 Free PMC article.

9

Potential of tumour cells for delivering oncolytic viruses.

Raykov Z, Rommelaere J. Raykov Z, et al. Among authors: rommelaere j. Gene Ther. 2008 May;15(10):704-10. doi: 10.1038/gt.2008.34. Epub 2008 Mar 20. Gene Ther. 2008. PMID: 18356816 Review.

10

Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity.

Raykov Z, Grekova S, Leuchs B, Aprahamian M, Rommelaere J. Raykov Z, et al. Among authors: rommelaere j. Int J Cancer. 2008 Jun 15;122(12):2880-4. doi: 10.1002/ijc.23472. Int J Cancer. 2008. PMID: 18360875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters